Vanguard Fiduciary Trust
XBIT icon

Vanguard Fiduciary Trust’s XBiotech XBIT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
92,365
+789
+0.9% +$1.91K ﹤0.01% 3553
2026
Q1 		$215K Buy
+91,576
New +$221K ﹤0.01% 3494

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust's XBIT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its XBiotech (XBIT) stake by 0.86% in Q2 2026, buying an estimated $1.91K and bringing the position to 92,365 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #3553.

Vanguard Fiduciary Trust first reported a position in XBIT in Q1 2026 and has held it in 2 quarters since. The position peaked at $215K in Q1 2026. 33 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • Vanguard Fiduciary Trust held 92,365 shares of XBiotech worth $212K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 789 XBiotech shares in Q2 2026, an estimated $1.91K.
  • XBiotech made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3553 holding.
  • Vanguard Fiduciary Trust first reported a position in XBiotech in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's XBiotech position peaked at $215K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.